LabGenomics Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Revenue	85,248	72,835	144,573	202,289	119,369	33,175
Other Revenue	93.24	291.33	199.59	117.98	109.43	-
Revenue	85,341	73,127	144,773	202,407	119,478	33,175
Revenue Growth (YoY)	16.61%	-49.49%	-28.47%	69.41%	260.14%	-
Cost of Revenue	55,190	41,598	48,652	77,521	48,159	20,227
Gross Profit	30,151	31,528	96,121	124,886	71,319	12,948
Selling, General & Admin	38,582	30,104	25,996	18,518	14,686	10,398
Research & Development	3,030	2,812	1,865	556.87	-	-
Other Operating Expenses	673.51	667.32	591.29	361.38	332.68	298.49
Operating Expenses	48,925	38,322	29,915	20,368	16,413	11,866
Operating Income	-18,774	-6,794	66,206	104,518	54,906	1,082
Interest Expense	-5,280	-4,969	-573.97	-208.03	-223.8	-415.79
Interest & Investment Income	3,878	4,565	1,111	154.71	111.28	292.98
Earnings From Equity Investments	-2,283	-1,969	-72.11	-46.37	-22.1	-274.33
Currency Exchange Gain (Loss)	-826.07	1,215	1,145	2,146	-1,171	-12.98
Other Non Operating Income (Expenses)	-3,379	-1,447	-448.52	90.13	128.96	444.22
EBT Excluding Unusual Items	-26,663	-9,399	67,367	106,655	53,729	1,116
Gain (Loss) on Sale of Investments	3,200	1,016	-3,929	2,531	-268.91	253.8
Gain (Loss) on Sale of Assets	-290.47	1,299	-44.62	0.9	-	11.61
Asset Writedown	8.11	-	-	-55.2	-1,636	-306.41
Other Unusual Items	-	-	-	-	-1.75	-
Pretax Income	-23,746	-7,085	63,393	109,132	51,822	1,075
Income Tax Expense	-2,043	-1,839	15,467	25,277	9,058	112.86
Earnings From Continuing Operations	-21,703	-5,246	47,926	83,855	42,764	962.42
Minority Interest in Earnings	527.89	571.89	471.27	-	2.91	-
Net Income	-21,175	-4,674	48,397	83,855	42,766	962.42
Net Income to Common	-21,175	-4,674	48,397	83,855	42,766	962.42
Net Income Growth	-	-	-42.28%	96.08%	4343.63%	-
Shares Outstanding (Basic)	74	74	68	68	66	62
Shares Outstanding (Diluted)	74	74	68	68	66	62
Shares Change (YoY)	4.81%	9.17%	0.20%	2.61%	6.06%	-
EPS (Basic)	-285.28	-63.22	714.67	1240.72	649.30	15.50
EPS (Diluted)	-285.28	-63.22	714.50	1240.50	649.30	15.50
EPS Growth	-	-	-42.40%	91.05%	4089.83%	-
Free Cash Flow	-13,077	-8,817	31,307	51,645	45,673	2,627
Free Cash Flow Per Share	-176.18	-119.26	462.30	764.15	693.42	42.30
Gross Margin	35.33%	43.11%	66.39%	61.70%	59.69%	39.03%
Operating Margin	-22.00%	-9.29%	45.73%	51.64%	45.95%	3.26%
Profit Margin	-24.81%	-6.39%	33.43%	41.43%	35.79%	2.90%
Free Cash Flow Margin	-15.32%	-12.06%	21.62%	25.52%	38.23%	7.92%
EBITDA	-10,356	-897.7	70,171	107,858	58,333	4,885
EBITDA Margin	-12.13%	-1.23%	48.47%	53.29%	48.82%	14.72%
D&A For EBITDA	8,418	5,896	3,965	3,340	3,427	3,803
EBIT	-18,774	-6,794	66,206	104,518	54,906	1,082
EBIT Margin	-22.00%	-9.29%	45.73%	51.64%	45.95%	3.26%
Effective Tax Rate	-	-	24.40%	23.16%	17.48%	10.50%
Advertising Expenses	-	80.68	100.91	74.86	31.5	46.36

Source: S&P Capital IQ. Standard template. Financial Sources.